Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,813 | 49 | 76.0% |
| Travel and Lodging | $889.81 | 4 | 24.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,152 | 16 | $0 (2022) |
| Orthofix International N.V. | $492.61 | 1 | $0 (2017) |
| Boston Scientific Corporation | $411.79 | 7 | $0 (2023) |
| AbbVie Inc. | $251.40 | 3 | $0 (2023) |
| GRT US Holding, Inc. | $189.00 | 1 | $0 (2022) |
| Stryker Corporation | $142.59 | 3 | $0 (2017) |
| Nevro Corp. | $135.71 | 1 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $121.96 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $121.23 | 2 | $0 (2018) |
| Purdue Pharma L.P. | $118.76 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $171.26 | 2 | Curonix LLC ($97.95) |
| 2023 | $233.81 | 3 | AbbVie Inc. ($124.99) |
| 2022 | $960.55 | 12 | Abbott Laboratories ($645.14) |
| 2021 | $316.88 | 3 | Abbott Laboratories ($181.17) |
| 2020 | $60.29 | 3 | Boston Scientific Corporation ($44.29) |
| 2019 | $178.79 | 2 | Amgen Inc. ($102.07) |
| 2018 | $654.47 | 10 | Abbott Laboratories ($232.87) |
| 2017 | $1,126 | 18 | Orthofix International N.V. ($492.61) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | Cash or cash equivalent | $97.95 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/03/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $73.31 | General |
| Category: Pain management | ||||||
| 11/09/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $82.19 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/23/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2023 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/23/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $93.23 | General |
| Category: Neuromodulation | ||||||
| 12/23/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Neuromodulation | ||||||
| 12/14/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Neuromodulation | ||||||
| 11/16/2022 | Abbott Laboratories | AXIUM (Device) | Travel and Lodging | In-kind items and services | $327.75 | General |
| Category: Neuromodulation | ||||||
| 11/10/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $69.80 | General |
| Category: Neuromodulation | ||||||
| 10/17/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $77.47 | General |
| Category: Neuromodulation | ||||||
| 10/17/2022 | Abbott Laboratories | SWIFT-LOCK (Device) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Neuromodulation | ||||||
| 09/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $120.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: Neuromodulation | ||||||
| 06/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $189.00 | General |
| Category: Pain Management | ||||||
| 03/26/2022 | Abbott Laboratories | AXIUM (Device) | Travel and Lodging | In-kind items and services | $9.67 | General |
| Category: Neuromodulation | ||||||
| 11/16/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $135.71 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/13/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $90.81 | General |
| Category: Neuromodulation | ||||||
| 06/25/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $90.36 | General |
| Category: Neuromodulation | ||||||
| 03/13/2020 | Abbott Laboratories | Prodigy Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Neuromodulation | ||||||
| 02/12/2020 | Boston Scientific Corporation | SUPERION (Device) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/03/2020 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/26/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $76.72 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/26/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $102.07 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 719 | 2,626 | $524,235 | $232,280 |
| 2022 | 23 | 1,131 | 3,021 | $535,884 | $240,210 |
| 2021 | 22 | 1,223 | 3,611 | $589,269 | $253,647 |
| 2020 | 15 | 1,051 | 3,490 | $527,995 | $215,729 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 1,804 | $405,325 | $182,443 | 45.0% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | Office | 2023 | 57 | 97 | $36,375 | $13,393 | 36.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 78 | 152 | $10,640 | $7,569 | 71.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 97 | $15,035 | $6,765 | 45.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 29 | 29 | $15,515 | $6,601 | 42.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 30 | 40 | $5,000 | $3,068 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,950 | $2,391 | 40.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 15 | 21 | $5,040 | $2,357 | 46.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 29 | 29 | $6,380 | $2,094 | 32.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 13 | 15 | $3,750 | $1,379 | 36.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 94 | 263 | $7,125 | $1,340 | 18.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 15 | 21 | $4,200 | $1,314 | 31.3% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 14 | 15 | $1,200 | $545.08 | 45.4% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 14 | 14 | $840.00 | $516.74 | 61.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 12 | 12 | $1,860 | $504.48 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 1,536 | $345,294 | $161,065 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 202 | $31,310 | $14,686 | 46.9% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 130 | 214 | $12,840 | $7,719 | 60.1% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve | Office | 2022 | 39 | 55 | $20,625 | $6,340 | 30.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 74 | 122 | $8,540 | $6,239 | 73.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 22 | 23 | $12,305 | $5,390 | 43.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2022 | 24 | 39 | $9,360 | $5,255 | 56.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 25 | 47 | $5,875 | $4,068 | 69.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 24 | 32 | $7,680 | $3,669 | 47.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 66 | 98 | $9,310 | $2,990 | 32.1% |
About Dr. Nathan Singer, M.D
Dr. Nathan Singer, M.D is a Pain Medicine healthcare provider based in Santa Maria, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1114108016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Singer, M.D has received a total of $3,703 in payments from pharmaceutical and medical device companies, with $171.26 received in 2024. These payments were reported across 53 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,813).
As a Medicare-enrolled provider, Singer has provided services to 4,124 Medicare beneficiaries, totaling 12,748 services with total Medicare billing of $941,866. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Santa Maria, CA
- Active Since 11/19/2007
- Last Updated 12/30/2021
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1114108016
Products in Payments
- Firebird (Biological) $492.61
- AXIUM (Device) $337.42
- PROCLAIM (Device) $297.14
- QULIPTA (Drug) $251.40
- Qutenza (Drug) $189.00
- Proclaim IPG (Device) $181.17
- Proclaim Family of SCS IPGs (Device) $143.51
- SPECTRA WAVEWRITER (Device) $142.45
- Omnia (Device) $135.71
- IVS - RF Cannulae/Needles (Device) $122.78
- MOVANTIK (Drug) $121.23
- Aimovig (Biological) $102.07
- Xtampza ER (Drug) $98.38
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $97.95
- INFINION (Device) $89.22
- SCS IPGs (Device) $83.76
- Penta SCS Leads (Device) $82.32
- LYRICA (Drug) $80.34
- SPRINT PNS System (Device) $73.31
- GENERAL THERAPIES (Device) $65.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.